Chemical Component Summary

Name5-BROMOVINYLDEOXYURIDINE
Identifiers5-[(E)-2-bromoethenyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
FormulaC11 H13 Br N2 O5
Molecular Weight333.13
TypeNON-POLYMER
Isomeric SMILESOC[C@H]1O[C@H](C[C@@H]1O)n1cc(\C=C\Br)c(=O)[nH]c1=O
InChIInChI=1S/C11H13BrN2O5/c12-2-1-6-4-14(11(18)13-10(6)17)9-3-7(16)8(5-15)19-9/h1-2,4,7-9,15-16H,3,5H2,(H,13,17,18)/b2-1+/t7-,8+,9+/m0/s1
InChIKeyODZBBRURCPAEIQ-PIXDULNESA-N

Chemical Details

Formal Charge0
Atom Count32
Chiral Atom Count3
Chiral AtomsC1', C3', C4'
Bond Count33
Aromatic Bond Count0
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB03312 Different stereochemistry
Name5-Bromovinyldeoxyuridine
Groupsexperimental

Drug Targets

NameSequence SearchPharmacological ActionActions
Thymidine kinaseMASYPCHQHASAFDQAARSRGHNNRRTALRPRRQQEATEVRPEQKMPTLL...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682